News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

6 Thoughts On President Trump And The Durability Of The Biotech Stock Rally



11/14/2016 7:33:20 AM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs
Investors have convinced themselves, at least temporarily, that President Donald Trump is going to make drug stocks great again.

Two widely owned exchange-traded funds, iShares Nasdaq Biotechnology (IBB) and the SPDR S&P Biotech ETF (XBI) , closed Wednesday up 8.9% and 10.4%, respectively, their largest one-day gains since October 13, 2008.

Shares of Pfizer (PFE) , the stodgiest pharma company in the world, rose 10% at one point during the day before closing up 7%. Regeneron Pharma (REGN) , Incyte (INCY) , Vertex Pharma (VRTX) , Biomarin (BMRN) , Shire (SHPG) and Celgene (CELG) all notched 10% or greater gains Wednesday.

Read at The Street.com


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES